End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.78 CNY | -1.80% | -4.39% | -21.65% |
Apr. 25 | Hualan Biological Vaccine Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 01 | Hualan Biological Vaccine Inc. Proposes Final Cash Dividend for 2023 | CI |
Sales 2024 * | 2.93B 406M | Sales 2025 * | 3.56B 494M | Capitalization | 13.07B 1.81B |
---|---|---|---|---|---|
Net income 2024 * | 1.04B 144M | Net income 2025 * | 1.28B 178M | EV / Sales 2024 * | 4.46 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.67 x |
P/E ratio 2024 * |
12.6
x | P/E ratio 2025 * |
10.2
x | Employees | 770 |
Yield 2024 * |
3.26% | Yield 2025 * |
3.86% | Free-Float | 14.02% |
1 day | -1.80% | ||
1 week | -4.39% | ||
Current month | -0.91% | ||
1 month | -4.89% | ||
3 months | -7.52% | ||
6 months | -27.93% | ||
Current year | -21.65% |
Managers | Title | Age | Since |
---|---|---|---|
Wen Jue An
CEO | Chief Executive Officer | 35 | 22-03-28 |
Cheng Yu Lü
DFI | Director of Finance/CFO | 43 | 20-05-31 |
Xiao Feng Cui
CTO | Chief Tech/Sci/R&D Officer | 49 | 17-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kang An
CHM | Chairman | 75 | 13-03-31 |
Bei Fan
BRD | Director/Board Member | 52 | 13-03-31 |
Ruo Wen Pan
BRD | Director/Board Member | 56 | 13-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 21.78 | -1.80% | 2,128,668 |
24-05-14 | 22.18 | +1.51% | 2,405,382 |
24-05-13 | 21.85 | -2.50% | 2,347,196 |
24-05-10 | 22.41 | -3.20% | 2,864,954 |
24-05-09 | 23.15 | +1.62% | 2,930,564 |
End-of-day quote Shenzhen S.E., May 14, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.65% | 1.81B | |
-0.07% | 91.42B | |
+2.76% | 41.08B | |
-9.06% | 34.26B | |
+55.32% | 25.27B | |
-16.61% | 15.27B | |
-9.14% | 12.81B | |
-12.11% | 11.6B | |
-43.61% | 11.42B | |
+7.79% | 9.16B |
- Stock Market
- Equities
- 301207 Stock